Nakamura K et al. |
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model. |
2018 |
Transpl. Immunol. |
pmid:28988984
|
Guan XF et al. |
Population Pharmacokinetic Modeling of Diltiazem in Chinese Renal Transplant Recipients. |
2018 |
Eur J Drug Metab Pharmacokinet |
pmid:28646274
|
Jiang JW et al. |
Optimal immunosuppressor induces stable gut microbiota after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:30228781
|
Park S et al. |
Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study. |
2018 |
Ann. Transplant. |
pmid:29891834
|
Gu B et al. |
Exploration of Fecal Microbiota Transplantation in the Treatment of Refractory Diarrhea After Renal Transplantation. |
2018 |
Transplant. Proc. |
pmid:29880353
|
Ma D et al. |
Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production. |
2018 |
Appl. Microbiol. Biotechnol. |
pmid:29666890
|
Hu T et al. |
Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy. |
2018 |
Medicine (Baltimore) |
pmid:29718866
|
Mei S et al. |
Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay. |
2018 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:29704799
|
Okada K et al. |
EBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus. |
2018 |
Int. J. Hematol. |
pmid:29516290
|
Jin L et al. |
Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats. |
2018 |
Transplantation |
pmid:29319618
|